Invesco Pharmaceuticals ETF (PJP) |
| 126.695 0.335 (0.27%) 10-28 12:36 |
| Open: | 125.03 |
| High: | 126.87 |
| Low: | 125.03 |
| Volume: | 4,200 |
| Market Cap: | 368(M) |
| PE Ratio: | 20.24 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 149.39 |
| Resistance 1: | 127.90 |
| Pivot price: | 124.55 |
| Support 1: | 122.26 |
| Support 2: | 118.78 |
| 52w High: | 131.68 |
| 52w Low: | 94.95 |
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 23 Oct 2026
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy? - The Motley Fool
Thu, 22 Oct 2026
Big Pharma vs. Breakthrough Biotech: Which ETF Has More Upside for Investors? - The Motley Fool
Sun, 11 Oct 2026
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens - The Motley Fool
Sun, 11 Oct 2026
Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP? - The Motley Fool
Fri, 02 Oct 2026
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Thu, 03 Sep 2026
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
